Consolidated Statement Of Income

OncoTherapy Science, Inc. - Filing #7733470

Concept 2017-04-01 to
2017-09-30
2016-04-01 to
2016-09-30
Consolidated statement of income
Statement of income
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
18,102,000 JPY
23,845,000 JPY
Rent expenses on land and buildings
5,865,000 JPY
6,039,000 JPY
Taxes and dues
3,578,000 JPY
40,275,000 JPY
Depreciation
3,951,000 JPY
4,928,000 JPY
Operating expenses
Selling, general and administrative expenses
137,987,000 JPY
185,469,000 JPY
Operating expenses
Operating profit (loss)
-1,425,641,000 JPY
-1,519,860,000 JPY
Ordinary profit (loss)
-1,422,985,000 JPY
-1,502,689,000 JPY
Operating expenses
Research and development expenses
1,489,059,000 JPY
1,368,776,000 JPY
General and administrative expenses
Salaries
Selling, general and administrative expenses
Non-operating income
2,680,000 JPY
17,170,000 JPY
Interest income
639,000 JPY
832,000 JPY
Extraordinary income
53,635,000 JPY
6,814,000 JPY
Non-operating income
Other
JPY
0 JPY
Non-operating expenses
Non-operating expenses
24,000 JPY
JPY
Profit (loss) before income taxes
-1,369,350,000 JPY
-1,495,875,000 JPY
Extraordinary income
Income taxes - current
2,268,000 JPY
2,268,000 JPY
Income taxes - deferred
-1,531,000 JPY
-897,000 JPY
Income taxes
737,000 JPY
1,370,000 JPY
Profit (loss)
-1,370,087,000 JPY
-1,497,245,000 JPY
Profit (loss) attributable to non-controlling interests
-2,932,000 JPY
JPY
Profit (loss) attributable to owners of parent
-1,367,154,000 JPY
-1,497,245,000 JPY
Other comprehensive income
Foreign currency translation adjustment
-1,148,000 JPY
923,000 JPY
Other comprehensive income
-1,148,000 JPY
923,000 JPY
Profit attributable to
Comprehensive income
-1,371,235,000 JPY
-1,496,322,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,368,302,000 JPY
-1,496,322,000 JPY
Comprehensive income attributable to non-controlling interests
-2,932,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.